Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia.
Meier ER, Creary SE, Heeney MM, Dong M, Appiah-Kubi AO, Nelson SC, Niss O, Piccone C, Quarmyne MO, Quinn CT, Saving KL, Scott JP, Talati R, Latham TS, Pfeiffer A, Shook LM, Vinks AA, Lane A, McGann PT. Meier ER, et al. Among authors: saving kl. Trials. 2020 Nov 27;21(1):983. doi: 10.1186/s13063-020-04912-z. Trials. 2020. PMID: 33246482 Free PMC article.
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial.
Hood AM, Strong H, Nwankwo C, Johnson Y, Peugh J, Mara CA, Shook LM, Brinkman WB, Real FJ, Klein MD, Hackworth R, Badawy SM, Thompson AA, Raphael JL, Yates AM, Smith-Whitley K, King AA, Calhoun C, Creary SE, Piccone CM, Hildenbrand AK, Reader SK, Neumayr L, Meier ER, Sobota AE, Rana S, Britto M, Saving KL, Treadwell M, Quinn CT, Ware RE, Crosby LE. Hood AM, et al. Among authors: saving kl. JMIR Res Protoc. 2021 May 21;10(5):e27650. doi: 10.2196/27650. JMIR Res Protoc. 2021. PMID: 34018965 Free PMC article.
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, Brandow AM, Lebensburger JD, Adesina O, Chou ST, Zemel BS, Smeltzer MP, Wang WC, Gurney JG. Hankins JS, et al. Among authors: saving kl. Pediatr Blood Cancer. 2018 Sep;65(9):e27228. doi: 10.1002/pbc.27228. Epub 2018 May 24. Pediatr Blood Cancer. 2018. PMID: 29797644
Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry.
Mendez GG, Nocek JM, Brambilla DJ, Jacobs S, Cole O, Kanter J, Glassberg J, Saving KL, Melvin CL, Gibson RW, Treadwell M, Jackson GL, King AA, Gordeuk VR, Kroner B, Hsu LL; Sickle Cell Disease Implementation Consortium. Mendez GG, et al. Among authors: saving kl. BMC Health Serv Res. 2024 Mar 6;24(1):291. doi: 10.1186/s12913-024-10717-6. BMC Health Serv Res. 2024. PMID: 38448911 Free PMC article.
Flow cytometry of neonatal platelet RNA.
Joseph MA, Adams D, Maragos J, Saving KL. Joseph MA, et al. Among authors: saving kl. J Pediatr Hematol Oncol. 1996 Aug;18(3):277-81. doi: 10.1097/00043426-199608000-00008. J Pediatr Hematol Oncol. 1996. PMID: 8689341
Imparied platelet--dense granule release in neonates.
Mankin P, Maragos J, Akhand M, Saving KL. Mankin P, et al. Among authors: saving kl. J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):143-7. doi: 10.1097/00043426-200003000-00012. J Pediatr Hematol Oncol. 2000. PMID: 10779028
27 results